Русский
Herd immunity to measles, rubella, and mumps viruses in the population of Moscow in 2016–2017
DOI: https://dx.doi.org/10.18565/epidem.2019.9.2.31-8
Nozdracheva A.V., Semenenko T.A., Rusakova E.V., Guseva E.V., Ivanova M.Yu., Gotvyanskaya T.P.
1) Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia, Moscow, Russia; 2) I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia
Objective. To estimate the immunological structure of the Moscow population to vaccine-preventable infections.
Materials and methods. Epidemiological, statistical, and serological (including 1951 serum samples) methods were used.
Results. In 2016–2017, among the total Moscow population, the immune stratum to measles, rubella, and mumps viruses averaged 54.2% [95% CI, 51.9–56.4], 89.1% [95% CI 87.7–90.5], and 69.5% [95% CI, 67.5–71.6], respectively. The proportion of persons immune to the causative agents of the above infections varied according to age; children and young people (their mean age was less than 35 years) are more susceptible than those in older age groups.
Conclusion. When non-immune children and young people get older, there may be an increase in the proportion of people susceptible to measles, rubella, and mumps among the Moscow adult population, which necessitates additional vaccination among the population previously unvaccinated.
Literature
1. [The immunization programme that saved millions of lives]. Bulletеn WHO 2014; (92): 314–5. http://www.who.int/bulletin/volumes/92/5/14-020514/ru/. (In Russ.). 2. [Immunization Coverage]. Informatsionnyy bulleten WHO. Mart 2017. http://www.who.int/mediacentre/factsheets/fs378/ru/ (In Russ.). 3. Semenenko T.A., Akimkin V.G. [Seroepidemiology in the surveillance of vaccine-preventable diseases]. Zhurnal microbiologii, epidemiologii i immunobiologii 2018; (2): 87–94. (In Russ.). 4. Lytkina I.N. Miheeva I.V. [Unifying management systems of epidemic process of measles, mumps and rubella]. Epidemiologiya i vaktsinoprofilaktika 2011; (1): 9–16. (In Russ.). 5. [WHO. Measles outbreaks across Europe threaten progress towards elimination. Copenhagen, 28 March 2017]. http://www.euro.who.int/ru/media-centre/sections/press-releases/2017/measles-outbreaks-across-europe-threaten-progress-towards-elimination . (In Russ.). 6. Semenenko T.A., Ezhlova E.B., Nozdracheva A.V., Rusakova E.V. [Manifestation features of the measles epidemic process in Moscow in 1992–2014]. Epidemiologiya i vaktsinoprofilaktika 2015; (6): 16–22. DOI: 2073-3046-2015-14-6-16-22 (In Russ.). 7. Onishchenko G.G., Popova A.Yu., Aleshkin V.A. (eds.). [Measles in Russia: the problem of elimination]. Moscow: Dynastiya, 2017. 552 р. (In Russ.). 8. [Infectious morbidity in the Russian Federation in January–December 2016 (according to form № 1 «Information on infectious and parasitic diseases»]. http://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php? ELEMENT_ID=7804 (In Russ.). 9. Mikheeva I.V. [The Epidemiological Situation of Mumps in the Russian Federation in 1995–2016]. Epidemiologiya i vaktsinoprofilaktika 2017; (6): 47–53. DOI: 10.31631/2073-3046-2017-16-6-47-53 (In Russ.). 10. Fine P., Eames K., Heymann D.L. «Herd immunity»: a rough guide. Clin. Infect. Dis. 2011; 52(7): 911–6. 11. Tikhonova N.T., Tsvirkun O.V., Gerasimova A.G., Basov A.A., Frolov R.A., Ezhlova E.B., Melnikova A.A., Vatolina A.A., Ivannikov N.Yu., Melnik T.N., Zakharyan A.I. [The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers]. Epidemiologiya i vaktsinoprofilaktika 2017; (6): 47–53. DOI: 10.31631/2073-3046-2017-16-6-14-20 (In Russ.). 12. Gotvyanskaya T.P., Nozdracheva A.V., Rusakova E.V., Evseeva L.F., Nikolaeva O.G., Polonskij V.O., Semenenko T.A. [The state of populatiоn immunity against preventable diseases among health care workers (on serum bank materials)]. Èpidemiologiâ i infekcionnye bolezni. Аktual’nye voprosy 2016; (3): 8–16. (In Russ.). 13. Nozdracheva A.V., Semenenko T.A., Mardanly S.G., Rotanov S.V. [Assessment of humoral immunity to measles and rubella among pregnant women in Moscow]. Zhurnal microbiologii, epidemiologii i immunobiologii 2017; (3): 91–4. (In Russ.). 14. Goleva O.V., Samoylova I.G., Murina E.A., Mundrueva A.A. [Characteristics of measles immunity]. Epidemiologiya i vaktsinoprofilaktika 2012; (6): 25–9. (In Russ.). 15. Gidding H.F., Quinn H.E., Hueston L., Dwyer D.E., Mcintyre P.B. Declining measles antibodies in the era of elimination: Australia’s experience. Vaccine 2018; (4): 507–13. DOI:10.1016/j.vaccine.2017.12.002 16. Kostinov M.P., Shmitko A.D., Bocharova A.I., Cherdancev A.P., Savis’ko A.A., Polishchuk V.B. [The level of IgG antibodies to measles virus in the cord blood of newborns taking into account the age of mothers]. Epidemiologiya i vaktsinoprofilaktika 2014; (3): 30–4. (In Russ.). 17. Briko N.I., Baranov A.A., Namazova-Baranova L.S. [Particulars of Informed Consent to Vaccination in Russia and Abroad]. Epidemiologiya i vaktsinoprofilaktika 2015; (4): 57–60. DOI: 10.31631/2073-3046-2015-14-4-57-60 (In Russ.). 18. Tsvirkun O.V., Gerasimova A.G., Tikhonova N.T., Ezhlova E.B., Melnikova A.A., Dubovitskaya E.L., Orlova O.S., Basov A.A., Frolov R.A. [Measles Cases by Age Group during the Elimination of Infection]. Epidemiologiya i vaktsinoprofilaktika 2017; (3): 18–25. DOI: 10.31631/2073-3046-2017-16-3-18-25 (In Russ.). 19. Toptygina A.P., Semikina E.L., Alioshkin V.A. [Changing of T-memory cell number after «Priorix» vaccination]. Rossiyskiy immunologicheskiy zhurnal 2012; (3): 253–8. (In Russ.).
About the Autors
Anna V. Nozdracheva, Researcher, Department of Epidemiology, Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; е-mail: nozdracheva0506@gmail.com; ORCID: http://orcid.org/ 0000-0002-8521-1741
Prof. Tatiana A. Semenenko, MD, Academician of the Russian Academy of Natural Sciences, Head, Department of Epidemiology, Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; Professor, Department of Infectology and Virology, Faculty of Preventive Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia; e-mail: semenenko@gamaleya.org; ORCID: http://orcid.org/0000-0002-6686-9011
Prof. Ekaterina V. Rusakova, MD, Leading Researcher, Scientific and Organizational Department, Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; e-mail: Rusakovaev5@yandex.ru; ORCID: http://orcid.org/0000-0002-3561-1499
Elena V. Guseva, Cand. Biol. Sci., Leading Researcher, Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; e-mail: guseva@gamaeya.org; ORCID: http://orcid.org/0000-0003-0931-9854
Marina Yu. Ivanova, Cand. Med. Sci., Associate Professor, Department of Histology, Cytology and Embryology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia; e-mail: ivanova_m_y@mail.ru; ORCID: http://orcid.org/ 0000-0002-7696-9809
Tatiana P. Gotvyanskaya, Cand. Biol. Sci., Senior Researcher, Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia, Moscow, Russia; Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; e-mail: gotvin@gamaleya.org; ORCID: http://orcid.org/0000-0002-0814-2666
Similar Articles
